Results 221 to 230 of about 12,392,515 (266)
Some of the next articles are maybe not open access.

Hemophilia B Leyden and a Similar Variant of Hemophilia A

New England Journal of Medicine, 1982
R, Ljung, I M, Nilsson
openaire   +2 more sources

Adeno-Associated Virus Gene Therapy for Hemophilia

Annual Review of Medicine, 2023
Benjamin J Samelson-Jones   +1 more
exaly  

Hemophilia B

Acta Haematologica, 2009
Dieter Metze   +199 more
  +4 more sources

Hemophilia A and Hemophilia B

2019
Mariasanta Napolitano, Craig M. Kessler
openaire   +1 more source

Hemophilia B Mutational Analysis

2003
Since the cloning of the factor IX gene in 1982 (1), there have been several strategies employed for the identification of mutations in the mutationally heterogeneous hemophilia B population. Initially, such strategies inevitably employed Southern blotting to screen for gross deletions (2) or restriction site alterations (3), and cloning of the ...
openaire   +2 more sources

Fitusiran (Qfitlia) for Hemophilia A and B

The Medical Letter on Drugs and Therapeutics
Fitusiran (Qfitlia – Sanofi), a subcutaneously injected, antithrombin-directed, small interfering ribonucleic acid (siRNA), has been approved by the FDA for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients ≥12 years old who have hemophilia A with or without factor VIII inhibitors or hemophilia B with or without ...
openaire   +2 more sources

Hemophilia B

2018
Hoda Motlagh   +2 more
openaire   +1 more source

Hemophilia B

2019
Surbhi Saini, Amy L. Dunn
openaire   +1 more source

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

Research and Practice in Thrombosis and Haemostasis, 2021
Alok Srivastava, Kathelijn Fischer
exaly  

Home - About - Disclaimer - Privacy